WGRX — Wellgistics Health Income Statement
0.000.00%
Last trade - 00:00- $11.66m
- $32.24m
- $18.13m
Annual income statement for Wellgistics Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0 | 18.1 | 23.3 |
| Cost of Revenue | ||||
| Gross Profit | — | — | 1.77 | -6.43 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 0.005 | 2.88 | 24.3 | 120 |
| Operating Profit | -0.005 | -2.88 | -6.15 | -96.7 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -0.005 | -2.9 | -6.86 | -101 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0.005 | -2.9 | -6.86 | -101 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.005 | -2.9 | -6.86 | -101 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.005 | -2.9 | -6.86 | -101 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0 | -0.056 | -0.145 | -1.21 |